Aspire Biopharma Holdings (ASBP) Interest Coverage Ratio (2024 - 2026)
Aspire Biopharma Holdings (ASBP) posted quarterly Interest Coverage Ratio of 1.03 for Q1 2026, up 98.08% year-over-year from 0.52 in Q1 2025, and down 247.79% quarter-over-quarter from 0.3 in Q4 2025.
Aspire Biopharma Holdings (ASBP) Interest Coverage Ratio (2024 - 2026) Analysis & Trends
Aspire Biopharma Holdings (ASBP) has reported Interest Coverage Ratio for 3 consecutive years, with 1.03 the latest figure, recorded in Q1 2026.
- In Q1 2026, Interest Coverage Ratio rose 98.08% year-over-year to 1.03; the TTM figure through Mar 2026 stood at 2.05 (changed N/A YoY), while the FY2025 annual figure was 2.27, down 67.02% from the prior year.
- Interest Coverage Ratio fell to 1.03 in Q1 2026 per ASBP's latest filing, from 0.3 in the prior quarter.
- Across five years, Interest Coverage Ratio topped out at 9.26 in Q4 2024 and bottomed at 53.66 in Q1 2025.
- Historically, Interest Coverage Ratio has averaged 9.3 across 3 years, with a median of 0.77 in 2025.
- Annual changes were most pronounced in 2025 — Interest Coverage Ratio plunged 103.2% — and 2026, when it soared 98.08%.
- Aspire Biopharma Holdings' Interest Coverage Ratio stood at 9.26 in 2024, then slumped by 103.2% to 0.3 in 2025, then tumbled by 247.79% to 1.03 in 2026.
- Business Quant data shows ASBP's Interest Coverage Ratio at 1.03 in Q1 2026, 0.3 in Q4 2025, and 0.77 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 2.82 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 76.86 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.08 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 1.42 |
| 10 | Aspire Biopharma Holdings | 8.30 Mn | -3.86 Mn | -30,086.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -35.71 |
| Mar 31, 2026 | -1.03 |
| Dec 31, 2025 | -0.30 |
| Sep 30, 2025 | -0.77 |
| Mar 31, 2025 | -53.66 |
| Dec 31, 2024 | 9.26 |